Friulimicin A, a formidable antibiotic widely employed in the biomedicine sector, showcases its prowess in fierce bacterial infection warfare. Its efficacy reaches paramount heights primarily against the relentless onslaught of Gram-positive bacteria, triumphing even over those harbouring resistant properties. Fathomably distinctive in its modus operandi, Friulimicin A emerges as the panacea for diverse maladies inflicted by bacterial pathogens, spanning cutaneous afflictions, respiratory dilemmas, and urogenital predicaments.
Friulimicin A is a cyclic lipopeptide antibiotic produced by Actinoplanes friuliensis, distinguished by its unique structure featuring a decapeptide core and lipid side chain. As a member of the calcium-dependent antibiotic family, it exhibits a distinctive mode of action targeting bacterial cell wall biosynthesis, which has garnered significant interest within the fields of microbiology, chemical biology, and natural product research. Its biochemical properties, including membrane interaction and specificity for lipid II precursors, make it an important tool for investigating antimicrobial mechanisms and the development of novel anti-infective agents. The compound's structural complexity and biological activity have positioned it as a valuable reference molecule for studies involving lipopeptide biosynthesis, resistance mechanisms, and structure-activity relationships.
Antibacterial Mechanism Elucidation: Friulimicin A serves as a critical probe in the investigation of bacterial cell wall biosynthesis inhibition. Its ability to bind selectively to undecaprenyl phosphate, a key lipid carrier in peptidoglycan assembly, enables researchers to dissect the molecular details of cell wall precursor trafficking and its disruption. Studies utilizing this lipopeptide facilitate the mapping of essential steps in Gram-positive bacterial cell wall construction, providing insights into vulnerabilities that can be exploited for antibacterial drug development.
Natural Product Biosynthesis Research: The compound's complex biosynthetic pathway, involving non-ribosomal peptide synthetases and tailored lipidation steps, makes it an exemplary model for exploring microbial secondary metabolite production. Researchers employ friulimicin derivatives and biosynthetic intermediates to unravel enzyme functions, gene cluster regulation, and the evolution of antibiotic biosynthetic machinery. Such studies advance understanding of modular peptide assembly and inform synthetic biology strategies for generating novel lipopeptide analogs.
Structure-Activity Relationship Studies: The decapeptide and lipid moieties of friulimicin A offer a rich framework for structure-activity relationship (SAR) investigations. By systematically modifying amino acid residues or lipid side chains, scientists can evaluate how specific structural features influence antibacterial potency, target affinity, and membrane interactions. These SAR studies are instrumental in guiding the rational design of next-generation lipopeptide antibiotics with improved efficacy and pharmacological properties.
Antimicrobial Resistance Mechanism Evaluation: The compound is frequently utilized in laboratory settings to assess mechanisms of resistance in Gram-positive bacteria, particularly those involving modifications to cell wall precursors or membrane components. By exposing bacterial cultures to friulimicin and analyzing adaptive responses, researchers can identify genetic and biochemical determinants of resistance, contributing to the broader understanding of how pathogens evade lipopeptide antibiotics and informing surveillance of emerging resistance phenotypes.
Analytical Standard and Reference Material: Owing to its well-characterized chemical structure and bioactivity, friulimicin A is often employed as a reference standard in analytical assays. It supports the validation of chromatographic methods, mass spectrometric profiling, and bioassay calibration in both research and industrial quality control environments. The use of this lipopeptide as a benchmark ensures accuracy and reproducibility in the quantification and identification of related compounds in complex biological or fermentation samples.
1. Myotropic activity of allatostatins in tenebrionid beetles
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More